Manuel Hernández Guerra
Manuel Hernández Guerra
DIGESTIVE SYSTEM SPECIALIST
See more specialists on
Sta.Cruz Tenerifesta.cruztenerife
en/medical-staff/gastroenterologist
Dr. Manuel Hernández Guerra is a leading specialist in the digestive system , currently practicing at the H.QS. COSTA ADEJE . His academic background includes an Official Doctoral Program in Medicine and Surgery from the Universitat de Barcelona, which he obtained in 2003 with Extraordinary Distinction. Among his scientific contributions, his recent publication in the Journal of Hepatology, entitled "Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome," published in January 2025, stands out. Throughout his career, he has demonstrated an unwavering commitment to medical excellence, solidifying his reputation within the medical community of the Canary Islands and nationally. He is also a member of the Asociación Española para el Estudio del Hígado. His dedication and professionalism are widely recognized, and his work continues to be a benchmark in the field of digestive health.
Key information
- Latest Publication:A slowdown of hepatitis C diagnosis in high-prevalence groups and with decentralized diagnostic strategies during the COVID-19 pandemic
- Belongs to:Asociacion Española para el Estudio del Higado
Professional Details
Hospital Quirónsalud Costa Adeje
SPECIALIST PHYSICIAN DIGESTIVE SYSTEM
March 2025
Hospital Quirónsalud Tenerife
SPECIALIST PHYSICIAN DIGESTIVE SYSTEM
January 2012
Hospital Universitario de Canarias
Head of Digestive System Service
January 2020
Hospital Universitario de Canarias
Resident tutor
January 2009
Hospital Universitario de Canarias
Researcher
January 2005
Hospital Clínic i Provincial de Barcelona
ISCIII Fellow
January 2002
Royal Infirmary of Edinburgh
Attending Physician
March 1998
Hospital Universitario Marques de Valdecilla
Resident Physician
January 1998
Hospital Universitario de Canarias
Attending Physician
January 1997
Study
Licensed in Medicine and Surgery and Director of Facilities of a Center Approved by the Consejo Radiodiagnóstico Médico de Seguridad Nuclear
Universidad de Navarra
1995
Doctorate
Universitat de Barcelona, España
2003
Specialized Healthcare Training
Medical Intern Resident
Another qualification
Stay at Hospital Clínic i Provincial de Barcelona
Another qualification
Stay at the Royal Infirmary of Edinburgh
Another qualification
Training of Research Personnel Using Experimental Animals
Another qualification
Estancia en University College London, Institute of Hepatology
Another qualification
Senior Technician in Occupational Risk Prevention with specialization in Industrial Hygiene, Workplace Safety, Ergonomics and Applied Psychosociology
Full Professor at University
Universidad de La Laguna
January 2022
Associate Professor
Universidad de La Laguna
January 2010
PI19/01756, Obesity, metabolic syndrome and kidney disease
Instituto de Salud Carlos III
2019
Efficacy of a blended learning model for Hepatitis C patients in the post-Covid19 era: a randomized clinical trial
Asociación Española para el Estudio del Hígado
2021
PI16/01835. EC4-1-00029-17. Phase III, prospective, multicenter, randomized clinical trial to evaluate the effect of rivaroxaban on portal vein thrombosis recanalization and survival in patients with cirrhosis and portal vein thrombosis
Biomedical Research Foundation Hospital Ramón y Cajal
2017
EC4-1-00024-15. Phase III clinical trial, prospective, multicenter, randomized study of the effect of rivaroxaban on survival and development of complications of portal hypertension in patients with cirrhosis
Instituto de Salud Carlos III; August Pi i Sunyer Biomedical Research Institute (IDIBAPS); Clinical Trials Unit (CTU) Clinic
2015
PI14/01243, Hepatic and systemic effects of chronic intermittent hypoxia in fatty liver disease. The endothelium and hypoxia-inducible factor as therapeutic targets
Health Research Fund (Strategic Action in Health)
2015
Clinical and radiological response of hepatocellular carcinoma (HCC) to locoregional therapy with deb-tace and sorafenib and influence of genetic polymorphisms involved in angiogenesis
DISA Foundation
2015
PI10/1914, Treatment of intrahepatic endothelial dysfunction by enhancing intercellular junctions: study in an experimental model of cirrhosis
Instituto de Salud Carlos III
2011
NCT01095185, Multicenter, randomized, double-blind, placebo-controlled study on the efficacy of adding statins to standard treatment in preventing recurrent bleeding in patients with liver cirrhosis and variceal bleeding
Instituto de Salud Carlos III
2010
PI30/08, Efficacy of the fecal occult blood immunoassay for the detection of advanced colorectal neoplasia in first-degree relatives of patients with colorectal cancer
CANARY ISLANDS FOUNDATION FOR RESEARCH AND HEALTH (FUNCIS)
2008
PI 07/0583, Pathophysiological role of intercellular junctions in the regulation of portal and splanchnic hemodynamics in cirrhosis
Health Research Fund (Strategic Action in Health)
2008
PI32/08, Usefulness of plasma determination of gelatinase B, CK19, CK20 and CEA in colorectal neoplasia screening in a population at familial risk of colorectal cancer
CANARY ISLANDS FOUNDATION FOR RESEARCH AND HEALTH (FUNCIS)
2008
PI 04/1031, Natural history and predictive factors of acute-on-chronic liver failure, implications for the development of therapeutic alternatives and assessment of a prevention strategy in high-risk patients
Instituto de Salud Carlos III
2004
PI 02/0739, Association of endoscopic band ligation with pharmacological treatment in the prevention of recurrent bleeding from esophageal varices. Relationship between hemodynamic response, clinical events and beta-2-adrenergic receptor polymorphisms
Instituto de Salud Carlos III
2002
PI 2001/0827, Involvement of the TNF alpha system in the pathogenesis of non-alcoholic steatohepatitis
Instituto de Salud Carlos III
2001
PI 00/0597, Comparative study between endoscopic ligation and nadolol versus ligation in the prevention of bleeding secondary to portal hypertension
Instituto de Salud Carlos III
2000
PI 99/0527, Role of nitric oxide in intestinal bacterial translocation in experimental cirrhosis
Instituto de Salud Carlos III
1999
QLRT-2001-01686, European Network for Vascular Disorders of the Liver
5th Framework Programme for Research Technological Development and Demonstration
2001
Comprehensive diagnosis of HDV in the general and vulnerable population
Asociación Española para el Estudio del Hígado
2024
Acceptance and feasibility of hepatitis C screening strategies in social reintegration centers with alternative sentences to prison and open regimes
Asociación Española para el Estudio del Hígado
2022
A slowdown of hepatitis C diagnosis in high-prevalence groups and with decentralized diagnostic strategies during the COVID-19 pandemic
Scientific article
Agreement between the perception of colon cleansing reported by patients and colon cleansing assessed by a validated colon cleansing scale
Scientific article
Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode
Scientific article
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration
Scientific article
Comparative Study of Predictive Models for the Detection of Patients at High Risk of Inadequate Colonic Cleansing
Scientific article
Cost-effectiveness Analysis of Single-Use Duodenoscope Applied to Endoscopic Retrograde Cholangiopancreatography
Scientific article
Decaying kidney function during cirrhosis correlates with remodeling of distal colon aldosterone target gene expression
Scientific article
Design and validation of an artificial intelligence system to detect the quality of colon cleansing before colonoscopy
Scientific article
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis
Scientific article
Efficacy, Efficiency, and Acceptability of Telemedicine for Inflammatory Bowel Disease Patients’ Follow-Up Care during the COVID-19 Pandemic
Scientific article
Hematological Composite Scores in Patients with Inflammatory Bowel Disease
Scientific article
Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice
Scientific article
Low penetrance of frequent ATP7B mutations explains the low prevalence of Wilson disease. Lessons from real-life registries
Scientific article
Measured glomerular filtration rate predicts liver related deaths better than estimated glomerular filtration rate in advanced chronic liver disease
Scientific article
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome
Scientific article
Postcolonoscopy colorectal cancer: Prevalence, categorization and root-cause analysis based on the World Endoscopic Organization system
Scientific article
Predicting survival in patients with ‘non-high-risk’ acute variceal bleeding receiving b-blockers+ligation to prevent re-bleeding
Scientific article
Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy
Scientific article
Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis
Scientific article
Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir
Scientific article
Reengagement strategies for hepatitis C patients lost to follow-up: A randomized clinical trial
Scientific article
Reproductive and pregnancy control in Wilson disease patients in Spain
Scientific article
Therapeutics in gastroenterology and hepatology. Chronic viral hepatitis
Book chapter
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
Scientific article
The Efficiency of Increased HCV Testing and Treatment Strategies in Spain to Achieve Elimination Goals
Scientific article
Asociacion Española para el Estudio del Higado
Make an appointment with this professional
Hospital Quirónsalud Costa Adeje
Urbanización San Eugenio, s/n
38660 Adeje S.C. Tenerife
© 2026 Quirónsalud - All rights reserved